Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02701153 · ClinicalTrials.gov registry record · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
A NA study of Recurrent Adult Soft Tissue Sarcoma, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT02701153 is a NA study of Recurrent Adult Soft Tissue Sarcoma that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 51 participants, below the 84-participant average among 11 other Recurrent Adult Soft Tissue Sarcoma trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02701153, a NA study of Recurrent Adult Soft Tissue Sarcoma, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- RADIATION Hypofractionated Radiation Therapy
- PROCEDURE Conventional Surgery
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2016-02-03 |
| Est. Completion | 2028-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02701153
The ClinicalTrials.gov registry entry for NCT02701153 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 11 other Recurrent Adult Soft Tissue Sarcoma trials with a reported enrollment target (39% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Recurrent Adult Soft Tissue Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02701153 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02701153 about?
NCT02701153 is a clinical study titled "Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort". This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer...
What is the current status of trial NCT02701153?
This trial is currently recruiting. It is a NA study. The enrollment target is 51 participants. The study started on 2016-02-03. Estimated completion is 2028-02-03.
What conditions does trial NCT02701153 study?
This clinical trial studies the following conditions: Recurrent Adult Soft Tissue Sarcoma.
What interventions are being tested in trial NCT02701153?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Hypofractionated Radiation Therapy (RADIATION), Conventional Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02701153?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02701153 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Adult Soft Tissue Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
COMPLETED · NA
-
Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
COMPLETED · Phase 2
-
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
COMPLETED · Phase 2
-
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
COMPLETED · Phase 2
-
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
COMPLETED · Phase 2
-
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.